Dergiler / Joint diseases and related surgery / 2022 / Cilt: 33 - Sayı: 1

Mortality rates of hip fracture patients with non-operative treatment

Sayfa
17–23
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Efforts and research are needed to reduce mortality and improve the quality of life.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In this study, we aimed to analyze patient mortality rate after non-operative treatment of hip fractures to determine the distribution of causes of death and to compare factors affecting mortality.
📊
Temel Bulgular & Veri:Patients and methods: Between January 2013 and March 2019, a total of 93 patients (17 males, 76 females; mean age: 86.0±7.4 years; range, 64 to 98 years) who had hip fractures and were treated non-operatively were analyzed retrospectively.
💡
Sonuç & Katkı:Efforts and research are needed to reduce mortality and improve the quality of life.
🔬Tür:Araştırma Makalesi
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: In this study, we aimed to analyze patient mortality rate after non-operative treatment of hip fractures to determine the distribution of causes of death and to compare factors affecting mortality. Patients and methods: Between January 2013 and March 2019, a total of 93 patients (17 males, 76 females; mean age: 86.0±7.4 years; range, 64 to 98 years) who had hip fractures and were treated non-operatively were analyzed retrospectively. Survival, date of death, and cause of death were collected and analyzed. Baseline demographics, pre-trauma ambulation, pre- and post-trauma residence status, American Society of Anesthesiologists Physical Status (ASA PS) classification, and Parker’s mobility score were compared with one-year mortality rates. Results: The mean follow-up of survivors was 16.1±11.9 (range, 6.3 to 79.6) months. The mean survival of non-survivors was 4.9±6.1 (range, 0.007 to 27.3) months. The 3-, 6-, 12-, and 24-month mortality rates were 40.9%, 53.3%, 74.4%, and 87.5%, respectively. Respiratory diseases (33.3%) and cardiovascular diseases (13.6%) were the main causes of death among the patients. There was no statistically significant difference between the patients’ age, sex, fracture site, pre-trauma ambulation, pre- and post-trauma residence status, ASA PS classification, Parker’s mobility score, and one-year mortality. Conclusion: A significant number of patients are still treated non-operatively after hip fractures, and they have a high mortality rate. Efforts and research are needed to reduce mortality and improve the quality of life.

🔖

Bu Makaleye Atıf Yap

LEE, J., SHIN, K., NAM, H., OH, M., SHIM, G. S. (2022). Mortality rates of hip fracture patients with non-operative treatment. Joint diseases and related surgery, Cilt: 33 - Sayı: 1, 17–23. https://ajindex.com/articles/559163

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Karapınar L, Turgut A, Kumbaracı M, Koca A. Evaluation of the quadrants of femoral neck-head in the cephalomedullary fixation of intertrochanteric fractures with a helical blade: Is inferior posterior quadrant also safe? A clinical study. Jt Dis Relat Surg 2021;32:93-100
  2. Sezgin EA, Markevičiūtė V, Širka A, Tarasevičius Š, Raina DB, Isaksson H, et al. Combined fracture and mortality risk evaluation for stratifying treatment in hip fracture patients: A feasibility study. Jt Dis Relat Surg 2020;31:163-8
  3. Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury 2018;49:1458-60
  4. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573-9
  5. Lee YK, Kim JW, Lee MH, Moon KH, Koo KH. Trend in the age-adjusted incidence of hip fractures in South Korea: Systematic review. Clin Orthop Surg 2017;9:420-3
  6. Cheung CL, Ang SB, Chadha M, Chow ES, Chung YS, Hew FL, et al. An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study. Osteoporos Sarcopenia 2018;4:16-21
  7. Parker MJ. Current concepts in the treatment of hip fracture. Z Gerontol Geriatr 2001;34:74-7
  8. Bhandari M, Swiontkowski M. Management of acute hip fracture. N Engl J Med 2017;377:2053-62
  9. Parker MJ, Myles JW, Anand JK, Drewett R. Cost-benefit analysis of hip fracture treatment. J Bone Joint Surg [Br] 1992;74:261-4
  10. Handoll HH, Parker MJ. Conservative versus operative treatment for hip fractures in adults. Cochrane Database Syst Rev 2008;(3):CD000337
  11. Tay E. Hip fractures in the elderly: Operative versus nonoperative management. Singapore Med J 2016;57:178-81
  12. Cram P, Yan L, Bohm E, Kuzyk P, Lix LM, Morin SN, et al. Trends in operative and nonoperative hip fracture management 1990-2014: A longitudinal analysis of Manitoba administrative data. J Am Geriatr Soc 2017;65:27-34
  13. Neuman MD, Fleisher LA, Even-Shoshan O, Mi L, Silber JH. Nonoperative care for hip fracture in the elderly: The influence of race, income, and comorbidities. Med Care 2010;48:314-20
  14. Miller BJ, Lu X, Cram P. The trends in treatment of femoral neck fractures in the Medicare population from 1991 to 2008. J Bone Joint Surg [Am] 2013;95:e132
  15. Moulton LS, Green NL, Sudahar T, Makwana NK, Whittaker JP. Outcome after conservatively managed intracapsular fractures of the femoral neck. Ann R Coll Surg Engl 2015;97:279-82
  16. Prommik P, Kolk H, Sarap P, Puuorg E, Harak E, Ku